Table 3 Outcomes in the PMX and mPSL alone groups before and after the stabilised IPTW
Before the stabilised IPTW | After the stabilised IPTW | |||
|---|---|---|---|---|
PMX group | mPSL alone group | PMX group | mPSL alone group | |
All patients, (n) | 199 | 5417 | 196 | 5435 |
In-hospital mortality, n (%) | 159 (79.9) | 4137 (76.4) | 164 (83.7) | 4151 (76.4) |
14-day mortality, n (%) | 41 (20.6) | 1152 (21.3) | 47 (24.0) | 1154 (21.2) |
28-day mortality, n (%) | 98 (49.2) | 2645 (48.8) | 111 (56.6) | 2659 (48.9) |
Length of hospital stay (days), median (IQR) | 28 (16–55) | 25 (15–45) | 23 (15–38) | 25 (15–45) |
Survivor, (n) | 40 | 1280 | 32 | 1284 |
Survival rate (%) | 20.1 | 23.6 | 16.3 | 23.6 |
Length of hospital stay (days), median (IQR) | 59 (34–87) | 40 (25–62) | 52 (31–79) | 39 (25–62) |